Necrotic tissue protein

Necrotic tissue proteins" is not a specific molecular target or receptor but rather a broad term referring to the collection of intracellular proteins released from cells undergoing necrosis. **Necrosis** is an uncontrolled form of cell death caused by external factors such as infection, toxins, trauma, or ischemia. When cells die by necrosis, their membranes rupture and release cellular contents—including various proteins—into the surrounding tissue. This process triggers inflammation and can cause collateral damage to neighboring healthy tissues[1][5][6]. Some commonly measured "necrotic tissue proteins" include HMGB1, LDH, myoglobin, enolase, certain heat shock proteins (like HSP90), and others; these are often used as biomarkers for cell injury or necrosis in clinical settings[4]. However, there is no single canonical "necrotic tissue protein," nor does this term refer to a defined therapeutic target such as a receptor or enzyme. Because "necrotic tissue protein" refers generically to any protein released from dead/dying cells in necrotic areas—and not to one specific molecule—it should not be considered a valid drug target name. The entry is too broad and non-specific for structured drug discovery purposes. In summary: > “Necrotic tissue proteins” describes various intracellular molecules passively released during pathological cell death by necrosis; it does not denote a unique molecular entity suitable for targeted therapy or structured database inclusion[4]. If you need information on specific markers of necrosis—such as HMGB1 or LDH—those should be queried individually using their precise names.